Literature DB >> 19711225

Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis.

Fermín Mearin1, Antonia Perelló, Agustin Balboa, Mónica Perona, Miquel Sans, Antonio Salas, Sandra Angulo, Josep Lloreta, Ruth Benasayag, María Asunción García-Gonzalez, Marc Pérez-Oliveras, Jordi Coderch.   

Abstract

OBJECTIVE: Functional gastrointestinal disorders (FGID) may appear after acute gastroenteritis. The aim of this study was to evaluate the possible mechanisms (inflammation, visceral hypersensitivity, psychological and immunogenetic factors) related to the development of postinfectious (PI) FGID 3 years after a Salmonella outbreak.
MATERIAL AND METHODS: Biopsies of the antrum, and right- and left colon from 16 PI-FGID patients, 8 PI control patients, and 18 healthy controls (H-controls) were processed for immunohistochemistry, cytokines, and mast-cell electron microscopy. DNA was typed for cytokine gene polymorphisms. Visceral sensitivity (satiety test and rectal barostat) and psychological factors (SCL-90 and vital events) were assessed.
RESULTS: The number of mast cells and T lymphocytes was similar among the groups in all locations. Mast cells within 5 microm of nerve fibers of both PI groups were increased compared to H-controls: (stomach: 5.6+/-1.2 versus 6.6+/-1.5 versus 2.5+/-1.1; right colon: 9.7+/-1.3 versus 8.0+/-1.3 versus 4.1+/-1.7; left colon: 8.9+/-0.9 versus 8.5+/-1.8 versus 2.2+/-2.0 per field) (p<0.05). No differences in the production of IL-1beta, IL-1ra, IL-6, and IL-10 or in their genotypes were found. PI-FGID patients showed a lower pain threshold to rectal distention (29+/-2 versus 37+/- 2 mmHg; p<0.05). Scores for anxiety (0.63+/-0.11 versus 0.28+/-0.14) and somatization (1.01+/-0.15 versus 0.45+/-0.15) were higher in PI-FGID patients than in PI controls (p<0.05). The number of stressful life events was not significantly different between both PI groups.
CONCLUSIONS: Three years after salmonellosis, PI-FGID patients showed no evidence of inflammation in the gastric or colonic mucosa, but visceral sensitivity and anxiety/somatization levels were increased. The close anatomical mast cell-nerve fibers relation does not seem to be related to the FGID but to the infection itself.

Entities:  

Mesh:

Year:  2009        PMID: 19711225     DOI: 10.1080/00365520903171276

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

Review 1.  The Traveling Microbiome.

Authors:  Mark S Riddle; Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 2.  Post-Infectious Irritable Bowel Syndrome.

Authors:  Yeong Yeh Lee; Chandramouli Annamalai; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2017-09-25

Review 3.  Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.

Authors:  Alexander C Ford; Nicholas J Talley
Journal:  J Gastroenterol       Date:  2011-02-18       Impact factor: 7.527

4.  Postinfectious onset in functional dyspepsia is a risk factor for weight loss.

Authors:  Jolien Schol; Florencia Carbone; Lieselot Holvoet; Karen Van den Houte; Esther Colomier; I-Hsuan Huang; Emidio Scarpellini; Tim Vanuytsel; Jan Tack
Journal:  J Gastroenterol       Date:  2022-01-29       Impact factor: 7.527

5.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

6.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

7.  An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome.

Authors:  Robin Spiller; Ching Lam
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

8.  Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness.

Authors:  Chad K Porter; Daniel Choi; Brooks Cash; Mark Pimentel; Joseph Murray; Larissa May; Mark S Riddle
Journal:  BMC Gastroenterol       Date:  2013-03-08       Impact factor: 3.067

9.  In Vivo and In Vitro Antinociceptive Effect of Fagopyrum cymosum (Trev.) Meisn Extracts: A Possible Action by Recovering Intestinal Barrier Dysfunction.

Authors:  Lina Liu; Xueting Cai; Jing Yan; Yi Luo; Ming Shao; Yin Lu; Zhiguang Sun; Peng Cao
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-17       Impact factor: 2.629

10.  Pimpinella anisum in the treatment of functional dyspepsia: A double-blind, randomized clinical trial.

Authors:  S Ashraffodin Ghoshegir; Mohammad Mazaheri; Alireza Ghannadi; Awat Feizi; Mahmoud Babaeian; Maryam Tanhaee; Mehrdad Karimi; Peyman Adibi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.